3 unknown, 1 completed, 1 enrolling by invitation, 1 not yet recruiting. 2 Phase 1, 2 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Enrolling by invitation 1, Unknown 1 |
| Phase 2 | 2 | Enrolling by invitation 1, Unknown 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Menstrual Irregularities: new trials by email Literature Review of Menstrual Irregularities trials Research Report on Menstrual Irregularities
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Role of Glucagon-like Peptide-1 Receptor Agonists in Menstrual Irregularities in Adolescent Females With Type 1 Diabetes Mellitus Dulaglutide - Menstrual Irregularities, Type1 Diabetes Mellitus | Phase 1 / Phase 2 | Enrolling by invitation | Ain Shams University | 50 | 2025-08-04 | 2026-06-05 |
| the Effect of Implanon on Menstrual Patterns Implanon (Etonogestrel) - Menstrual Irregularities | Not yet recruiting | Assiut University | 200 | 2025-05-01 | 2025-04-23 | |
| The Impact of Hormonal Contraceptive Use and Lifestyle Factors on Fracture Risk and Bone Quality in Young Female Adults Osteoporosis, Osteopenia | Unknown | Bundeswehr University Munich | 150 | 2023-10-01 | 2024-09-23 | |
| Comparison of Metformin and Pioglitazone in Regulating Menstrual Irregularities and Hyperandrogenism TAB METFORMIN, TAB PIOGLITAZONE - Menstrual Irregularities, Hyperandrogenism | Phase 1 / Phase 2 | Unknown | Dow University of Health Sciences | 110 | 2018-06-18 | 2018-11-29 |
| Hemocoagulation and Lipoperoxidation in Women Using Combined Oral Contraceptives, Correction by Antioxidants 20 mcg ethinylestradiol /3 mg drospirenone, 20 mcg ethinylestradiol/3 mg drospirenone and Selmevit, 30 mcg ethinylestradiol/3 mg drospirenone - Polycystic Ovarian Syndrome, Hyperandrogenism | Phase 4 | Unknown | Tyumen State Medical Academy | 200 | 2013-12-01 | 2014-11-21 |
| Study of Menstrual Irregularities and Endometrial Pathology in Women Undergoing Bariatric Surgery Morbid Obesity, Endometrial Pathology | Completed | University of Virginia | 100 | 2011-01-01 | 2015-06-02 |
Menstruation Disturbances (6) · Hyperandrogenism (2) · Bone Diseases, Metabolic (1) · Contraception Behavior (1) · Motor Activity (1) · Obesity, Morbid (1) · Osteoporosis (1) · Polycystic Ovary Syndrome (1)
Pathologic Processes (6) · Pathological Conditions, Signs and Symptoms (6) · 46, XX Disorders of Sex Development (2) · Adrenogenital Syndrome (2) · Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Disorders of Sex Development (2) · Endocrine System Diseases (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Gonadal Disorders (2) · Male Urogenital Diseases (2) · Nutritional and Metabolic Diseases (2) · Urogenital Abnormalities (2) · Urogenital Diseases (2)
Cyproterone acetate, ethinyl estradiol drug combination (1) · Ethinyl Estradiol (1) · Metformin (1) · Pioglitazone (1) · drospirenone and ethinyl estradiol combination (1) · dulaglutide (1) · etonogestrel (1)
Ain Shams University (1) · Assiut University (1) · Bundeswehr University Munich (1) · Dow University of Health Sciences (1) · Tyumen State Medical Academy (1) · University of Virginia (1)
Egypt (1) · Germany (1) · Pakistan (1) · Russia (1) · United States (1)
Bader F Zuberi, FCPS (1) · Susan Modesitt, MD (1)